Co-Trimoxazole Tablets IP combine two antimicrobial agents, trimethoprim and sulfamethoxazole, in fixed proportions. Each tablet typically contains 80mg trimethoprim and 400mg sulfamethoxazole. This combination antibiotic is effective against a broad spectrum of bacterial infections, including urinary tract infections, respiratory tract infections, and skin infections. By inhibiting different steps in bacterial folate synthesis, Co-Trimoxazole exerts a synergistic effect, effectively killing or inhibiting the growth of susceptible bacteria. These tablets are prescribed for various bacterial infections, providing reliable relief and support. Always use under healthcare professional guidance.